In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

Item
http://www.wikidata.org/entity/Q35999976
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Gene Therapy 2017: Progress and Future Directions.Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.Virus-Derived Peptides for Clinical Applications.Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond.Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.Exocytosis proteins as novel targets for diabetes prevention and/or remediation?Retro-Orbital Venous Sinus Delivery of rAAV9 Mediates High-Level Transduction of Brain and Retina Compared with Temporal Vein Delivery in Neonatal Mouse Pups.A splice-site variant in FLVCR1 produces retinitis pigmentosa without posterior column ataxia.Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Engineered viral vectors for functional interrogation, deconvolution, and manipulation of neural circuits.SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis.In vivo methods for acute modulation of gene expression in the central nervous systemSystemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyNeuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
P2860

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

Item
http://www.wikidata.org/entity/Q35999976
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@ast
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@en
type
label
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@ast
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@en
prefLabel
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@ast
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932